Companies /Healthcare

Merck & Co Inc

NYSE: MRK Drug Manufacturers - General
$148.35
▼ $1.19 (−0.80%) today
Markets closed · 11:10am ET

MRK Coverage

Page 27
10:05am ET
Health and Healthcare

Merck Moves Ahead With Late-Stage Trial Win

Shares of Merck had a boost early Monday after the firm announced that its Phase 3 trial of Keytruda for the treatment of metastatic non-small cell lung cancer met its primary endpoint.

MRK
Chris Lange
10:05am ET
Health and Healthcare

What Has Tanked Incyte and NewLink Genetics

Incyte saw its shares make a sharp left turn on Friday after the firm gave an update on its late-stage collaboration with Merck. NewLink Genetics felt the sting as well.

Chris Lange